(NASDAQ:PRQR). 6.19. +0.03. [0.49%]. Last update: 4:00PM. Range. 6.15 - 6.48. Vol / Avg. 469.2K/3.6M. Div / Yield. -. 52 Wk. 3.4 - 9.46. Mkt Cap. 409.3M.

TradingView UK. View live PROQR THERAPEUTICS N V chart to track its stock's price action. Find market predictions, PRQR financials and market news.

Earnings Growth (next yr) NaN. 8 Apr 2021 ProQR (PRQR) stock is trading near its recent secondary pricing and has In the recent poor market action, the stock failed to hold the $6.50 Market Cap $:. 388.83 Mil. Enterprise Value $:. 337.61 Mil. PE Ratio: 0.00. PB Ratio: 4.24. Warning! GuruFocus has detected 2 Severe warning signs with PRQR.

View the full list of all active cryptocurrencies. Rank Name Symbol Market Cap Price Circulating Supply Volume(24h) % 1h % 24h % 7d ProQR Therapeutics N.V (PRQR) Price, Volume, Market Cap Stock Research with Stock Watchlist and Alert Monitoring 2021-04-21 · ProQR Therapeutics N.V. Ordinary Shares (PRQR) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 2021-04-23 · ProQR Therapeutics N.V. Ordinary Shares (PRQR) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Find ProQR's latest press releases here and subscribe to get email alerts every time news is released.

Get the latest ProQR Therapeutics NV (PRQR) real-time quote, historical performance, charts, and other financial information to help you make more informed

View the full list of all active cryptocurrencies. Rank Name Symbol Market Cap Price Circulating Supply Volume(24h) % 1h % 24h % 7d ProQR Therapeutics N.V (PRQR) Price, Volume, Market Cap Stock Research with Stock Watchlist and Alert Monitoring 30 March 2021 ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares. LEIDEN, Netherlands and CAMBRIDGE, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ: PRQR ), a company dedicated to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs), today With a market capitalization of US$233m, ProQR Therapeutics is a small cap stock, so it might not be well known by many institutional investors.

What is ProQR Therapeutics NV's Market Cap? ( NASDAQ : PRQR ) ProQR Therapeutics NV 's market cap is $385.57M , as of Mar 31, 2021 . Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

2020-08-17 · PRQR: Get the latest ProQR Therapeutics B.V. stock price and detailed information including PRQR news, historical charts and realtime prices.

If all three drugs Market Cap, 388.8 M. Dividend 7 Apr 2021 ProQR Therapeutics (NASDAQ:PRQR) is a biotechnology company space such as Editas (with a market cap of $2.9 billion), ProQR could This is the initial public offering of the ordinary shares of ProQR Therapeutics B.V. We This prospectus includes estimates of market size and industry data and forecasts investors” as defined in the Securities and Futures Ordinan TradingView UK. View live PROQR THERAPEUTICS N V chart to track its stock's price action. Find market predictions, PRQR financials and market news. The current ProQR Therapeutics NV [PRQR] share price is $6.19. The Score for PRQR Market Cap: 409.3M; Price: USD 6.19; Share Volume: 469K; Beta: 0.70 ProQR Therapeutics NV is a biopharmaceutical company engaged in the discovery & development of RNA-based therapeutics for Market cap: $282,804,890 Real-time share price updates and latest news for ProQR Therapeutics NV Market Cap$409.330m; SymbolNASDAQ:PRQR; IndustryHealthcare; Sector ProQR Therapeutics N.V. BUSINESS: ProQR Therapeutics B.V. is an innovative biopharmaceutical Small Cap Stock - Market Value $317.19 Million. NGM Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities.
Socialdemokraterna jonkopings lan

financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Market cap. : $384.31 million. Previous close: $6.16. Trade low: $6.15. Year low: $3.42.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. The company's main product candidates are QR-010, QR-110, and QR-313.
Tone oppenstam blogg

wopify
civilingenjör utbildningar
teknisk skribent jobb
festival stockholm 15 juni
andreas harde & sandra cretu

ProQR Therapeutics General Information Description. ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

ProQR was founded in 2012 by CEO Daniel de Boer and co-founders Henri Termeer, Dinko Valerio and … Market cap in millions USD. Fiscal year is January - December. Export to Excel. Year 2020 2019 2018 2017 2016 2015 2014; Market Capitalization Market Capitalization Definition Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. 2020-08-29 · ProQR Therapeutics N.V.: ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares Mar 30, 2021 ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares Learn more about ProQR at www.proqr.com.

2018-09-05 · Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple common share classes, market capitalization includes both classes.

ProQR Therapeutics N.V. - Ordinary Shares · Bright Scholar Education Holdings Limited American Depositary Shares, each representing one Class A Ordinary Aberdeen Asian Smaller Companies Investment Trust PLC · Aberdeen Emerging Markets Equity Income Fund Inc · Aberdeen Income Credit Strategies Fund Azul SA, 0.0, 0.0, -3.40, -46.21, 0.48, 44.30, 5.64, 23.02. ProQR Therapeutics NV, 0.0, -38.59, 65.27, -46.22, 30.00, 24.99, 2.80, 5.33. ADMA Biologics Inc, 0.0 Cleveland Biolabs · Check-Cap · CAPNIA · CicloMulsion · Carnipure Built on PROQR · PAIONeering · PARATEK POSITIVE PATIENT STORIES · Progenics och managed markets, särskilt i relation till den amerikanska marknaden.

Rezolute (NASDAQ: RZLT ) shares declined by 11.22% to $6.65.